FRI0401 Initial manifestation determines clinical entity and course in patients with anti-centromere antibody: a single center longitudinal retrospective cohort study

M Tsukamoto; K Suzuki; N Seta; T Takeuchi

doi:10.1136/annrheumdis-2017-eular.5692

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Poster Presentations

Scleroderma, myositis and related syndromes

FRI0401 Initial manifestation determines clinical entity and course in patients with anti-centromere antibody: a single center longitudinal retrospective cohort study

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Tsukamoto M, Suzuki K, Seta N, et al

FRI0401 Initial manifestation determines clinical entity and course in patients with anti-centromere antibody: a single center longitudinal retrospective cohort study

Annals of the Rheumatic Diseases 2017;76:639.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password